About Medizinische Universitatsklinik - Bonn, Immunologische Ambulanz CRS
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Medizinische Universitatsklinik - Bonn, Immunologische Ambulanz CRS
During the past decade, Medizinische Universitatsklinik - Bonn, Immunologische Ambulanz CRS conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
AtriCure Exclusion of the LAA in Patients Undergoing Concomitant Cardiac Surgery
2008-09-01
2011-10-01
Completed
70
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Medizinische Universitatsklinik - Bonn, Immunologische Ambulanz CRS"
#1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "ANRS, Emerging Infectious Diseases" with 1 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were
collaborators in the rest 22 trials.
According to Clinical.Site data, the most researched conditions in "Medizinische Universitatsklinik - Bonn, Immunologische Ambulanz CRS" are
"HIV Infection" (1 trials), "Influenza" (1 trials), "Influenza and Other Novel Respiratory Viruses" (1 trials), "Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV)" (1 trials) and "Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)" (1 trials). Many other conditions were trialed in "Medizinische Universitatsklinik - Bonn, Immunologische Ambulanz CRS" in a lesser frequency.
Most popular intervention types in "Medizinische Universitatsklinik - Bonn, Immunologische Ambulanz CRS" are "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "All licensed antiretroviral medications" (1 trials). Other intervention names were less common.
The vast majority of trials in "Medizinische Universitatsklinik - Bonn, Immunologische Ambulanz CRS" are
3 trials for "All" genders.
Clinical Trials Status at Medizinische Universitatsklinik - Bonn, Immunologische Ambulanz CRS
Currently, there are NaN active trials in "Medizinische Universitatsklinik - Bonn, Immunologische Ambulanz CRS".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Medizinische Universitatsklinik - Bonn, Immunologische Ambulanz CRS,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Medizinische Universitatsklinik - Bonn, Immunologische Ambulanz CRS, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".